Connect to other sites within the UBM Medica Network
The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.
I'm a DO--And My Day Job Is Teaching
“Doctor” comes from the Latin docēre, “to teach.”
An Older Woman at A1c Goal with Asymptomatic Hypoglycemia: What Next?
RM is an active 78-year-old woman with no complaints about her health or her medications. Then she tells you about her home blood glucose readings.
Frequent Antibiotic Use Raises the Risk of Type 2 Diabetes
Authors of a new study note that an observed link between antibiotics and diabetes risk may be yet another result of changing levels and diversity of gut bacteria.
Metformin Trims Colorectal Cancer Risk in Diabetes
The drug appeared to reduce the risk in the first study to assess its effects on younger patients with diabetes in the United States.
Diabetes News Quiz
Take this 3-question mini-quiz to see if you’re up-to-date on diabetes and breast cancer risk, gestational diabetes and depression, and sedentary time and diabetes development.
GLP-1 Receptor Agonists Go Head-to-Head
This short slide show summarizes results of 8 phase III clinical trials, revealing favorable class efficacy and also differences that should be considered before treatment selection.
SGLT2 Inhibitors and Fracture Risk: A Review of What We Know
It's probably too early to pass judgment but data from clinical trials point to decreased bone mineral density and increased treatment-emergent fractures in patients taking the new antidiabetes drugs.
Five Top Papers From 2014 That Will Impact Your Practice
New drugs that treat stubborn illness seen often in primary care lead this group of Top 5 Papers for 2014. Type 2 diabetes, cryptogenic stroke, and hep-C are key targets.
By clicking Accept, you agree to become a member of the UBM Medica Community.